🧪Trial version — For internal lab review only. Not for clinical or production use.
VaxIQ/Yellow Fever (YF-17D)
← Back to VaxIQ

Yellow Fever (YF-17D)

Yellow Fever Vaccine 17D

Tier 1 · EPI/CoreVaccineCuration in progress

Platform: Live attenuated viral

Live attenuated vaccine that protects against yellow fever, a viral hemorrhagic disease transmitted by mosquitoes in tropical regions.

systems vaccinologyYEL-ANDYEL-AVDinnatePulendran

PubMed References

PMID 19029902Querec/Pulendran. Systems biology YF-17D immunogenicity. Nat Immunol 2008.
PMID 19309249Domingo/Niedrig. Safety of 17D yellow fever vaccines. Expert Opin Drug Saf 2009.

Immunology Sections

Curated section analysis in progress

Structured immunology sections — mechanism, immune response, molecular signatures, correlates of protection, and more — are being prepared by the Precision Vaccines Program team. In the meantime, verified references and live literature from PubMed, Semantic Scholar, and Wikipedia are available below.

MechanismImmune ResponseMolecular & Immune SignaturesCorrelates of ProtectionOpen QuestionsImmunogenicitySafetyInfection Immunology

Verified References

PMID 19029902Querec/Pulendran. Systems biology YF-17D immunogenicity. Nat Immunol 2008.
PMID 19309249Domingo/Niedrig. Safety of 17D yellow fever vaccines. Expert Opin Drug Saf 2009.

Wikipedia Overview

Full article ↗
Yellow fever vaccine

Yellow fever vaccine is a vaccine that protects against yellow fever. Yellow fever is a viral infection that occurs in Africa and South America. Most people begin to develop immunity within ten days of vaccination and are 99% protected within one month, and this appears to be lifelong. The vaccine can be used to control outbreaks of disease. It is given either by injection into a muscle or just under the skin.

PubMed Literature

Search PubMed ↗

No PubMed results retrieved.

Semantic Scholar

Search S2 ↗

No Semantic Scholar results retrieved.